aluates Reports

$ 0.0

Global Inactivated Polio Virus Vaccine Market Research Report 2025

Published Date: February 2025

Report Code: QYRE-Auto-20Q11524

Global Inactivated Polio Virus Vaccine Market Research Report 2022

BUY CHAPTERS

Global Inactivated Polio Virus Vaccine Market Research Report 2025

Code: QYRE-Auto-20Q11524

Report

February 2025

Pages:67

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Sanofi

GSK

Serum Institute (Bilthoven Biologicals)

IMBCA

Inactivated Polio Virus Vaccine Market Size

The global market for Inactivated Polio Virus Vaccine was valued at US$ 744 million in the year 2024 and is projected to reach a revised size of US$ 1002 million by 2031, growing at a CAGR of 4.4% during the forecast period.

Inactivated Polio Virus Vaccine Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Inactivated Polio Virus Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inactivated Polio Virus Vaccine.

The Inactivated Polio Virus Vaccine market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Inactivated Polio Virus Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Inactivated Polio Virus Vaccine companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Inactivated Polio Virus Vaccine Market Report

Report Metric	Details
Report Name	Inactivated Polio Virus Vaccine Market
Accounted market size in year	US$ 744 million
Forecasted market size in 2031	US$ 1002 million
CAGR	4.4%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Type I Type II Type III
Segment by Application	Hospital Clinic
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Sanofi, GSK, Serum Institute (Bilthoven Biologicals), IMBCA
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Inactivated Polio Virus Vaccine company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Inactivated Polio Virus Vaccine Market growing?

Ans: The Inactivated Polio Virus Vaccine Market witnessing a CAGR of 4.4% during the forecast period 2025-2031.

What is the Inactivated Polio Virus Vaccine Market size in 2031?

Ans: The Inactivated Polio Virus Vaccine Market size in 2031 will be US$ 1002 million.

Who are the main players in the Inactivated Polio Virus Vaccine Market report?

Ans: The main players in the Inactivated Polio Virus Vaccine Market are Sanofi, GSK, Serum Institute (Bilthoven Biologicals), IMBCA

What are the Application segmentation covered in the Inactivated Polio Virus Vaccine Market report?

Ans: The Applications covered in the Inactivated Polio Virus Vaccine Market report are Hospital, Clinic

What are the Type segmentation covered in the Inactivated Polio Virus Vaccine Market report?

Ans: The Types covered in the Inactivated Polio Virus Vaccine Market report are Type I, Type II, Type III

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Inactivated Polio Virus Vaccine Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Type I

1.2.3 Type II

1.2.4 Type III

1.3 Market by Application

1.3.1 Global Inactivated Polio Virus Vaccine Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Clinic

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Inactivated Polio Virus Vaccine Market Perspective (2020-2031)

2.2 Global Inactivated Polio Virus Vaccine Growth Trends by Region

2.2.1 Global Inactivated Polio Virus Vaccine Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Inactivated Polio Virus Vaccine Historic Market Size by Region (2020-2025)

2.2.3 Inactivated Polio Virus Vaccine Forecasted Market Size by Region (2026-2031)

2.3 Inactivated Polio Virus Vaccine Market Dynamics

2.3.1 Inactivated Polio Virus Vaccine Industry Trends

2.3.2 Inactivated Polio Virus Vaccine Market Drivers

2.3.3 Inactivated Polio Virus Vaccine Market Challenges

2.3.4 Inactivated Polio Virus Vaccine Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Inactivated Polio Virus Vaccine Players by Revenue

3.1.1 Global Top Inactivated Polio Virus Vaccine Players by Revenue (2020-2025)

3.1.2 Global Inactivated Polio Virus Vaccine Revenue Market Share by Players (2020-2025)

3.2 Global Inactivated Polio Virus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Inactivated Polio Virus Vaccine Revenue

3.4 Global Inactivated Polio Virus Vaccine Market Concentration Ratio

3.4.1 Global Inactivated Polio Virus Vaccine Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Inactivated Polio Virus Vaccine Revenue in 2024

3.5 Global Key Players of Inactivated Polio Virus Vaccine Head office and Area Served

3.6 Global Key Players of Inactivated Polio Virus Vaccine, Product and Application

3.7 Global Key Players of Inactivated Polio Virus Vaccine, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Inactivated Polio Virus Vaccine Breakdown Data by Type

4.1 Global Inactivated Polio Virus Vaccine Historic Market Size by Type (2020-2025)

4.2 Global Inactivated Polio Virus Vaccine Forecasted Market Size by Type (2026-2031)

5 Inactivated Polio Virus Vaccine Breakdown Data by Application

5.1 Global Inactivated Polio Virus Vaccine Historic Market Size by Application (2020-2025)

5.2 Global Inactivated Polio Virus Vaccine Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Inactivated Polio Virus Vaccine Market Size (2020-2031)

6.2 North America Inactivated Polio Virus Vaccine Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Inactivated Polio Virus Vaccine Market Size by Country (2020-2025)

6.4 North America Inactivated Polio Virus Vaccine Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Inactivated Polio Virus Vaccine Market Size (2020-2031)

7.2 Europe Inactivated Polio Virus Vaccine Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Inactivated Polio Virus Vaccine Market Size by Country (2020-2025)

7.4 Europe Inactivated Polio Virus Vaccine Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Inactivated Polio Virus Vaccine Market Size (2020-2031)

8.2 Asia-Pacific Inactivated Polio Virus Vaccine Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Inactivated Polio Virus Vaccine Market Size by Region (2020-2025)

8.4 Asia-Pacific Inactivated Polio Virus Vaccine Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Inactivated Polio Virus Vaccine Market Size (2020-2031)

9.2 Latin America Inactivated Polio Virus Vaccine Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Inactivated Polio Virus Vaccine Market Size by Country (2020-2025)

9.4 Latin America Inactivated Polio Virus Vaccine Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Inactivated Polio Virus Vaccine Market Size (2020-2031)

10.2 Middle East & Africa Inactivated Polio Virus Vaccine Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Inactivated Polio Virus Vaccine Market Size by Country (2020-2025)

10.4 Middle East & Africa Inactivated Polio Virus Vaccine Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Sanofi

11.1.1 Sanofi Company Details

11.1.2 Sanofi Business Overview

11.1.3 Sanofi Inactivated Polio Virus Vaccine Introduction

11.1.4 Sanofi Revenue in Inactivated Polio Virus Vaccine Business (2020-2025)

11.1.5 Sanofi Recent Development

11.2 GSK

11.2.1 GSK Company Details

11.2.2 GSK Business Overview

11.2.3 GSK Inactivated Polio Virus Vaccine Introduction

11.2.4 GSK Revenue in Inactivated Polio Virus Vaccine Business (2020-2025)

11.2.5 GSK Recent Development

11.3 Serum Institute (Bilthoven Biologicals)

11.3.1 Serum Institute (Bilthoven Biologicals) Company Details

11.3.2 Serum Institute (Bilthoven Biologicals) Business Overview

11.3.3 Serum Institute (Bilthoven Biologicals) Inactivated Polio Virus Vaccine Introduction

11.3.4 Serum Institute (Bilthoven Biologicals) Revenue in Inactivated Polio Virus Vaccine Business (2020-2025)

11.3.5 Serum Institute (Bilthoven Biologicals) Recent Development

11.4 IMBCA

11.4.1 IMBCA Company Details

11.4.2 IMBCA Business Overview

11.4.3 IMBCA Inactivated Polio Virus Vaccine Introduction

11.4.4 IMBCA Revenue in Inactivated Polio Virus Vaccine Business (2020-2025)

11.4.5 IMBCA Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Sanofi

GSK

Serum Institute (Bilthoven Biologicals)

IMBCA

List of Tables

Table 1. Global Inactivated Polio Virus Vaccine Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Type I

Table 3. Key Players of Type II

Table 4. Key Players of Type III

Table 5. Global Inactivated Polio Virus Vaccine Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Inactivated Polio Virus Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Inactivated Polio Virus Vaccine Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Inactivated Polio Virus Vaccine Market Share by Region (2020-2025)

Table 9. Global Inactivated Polio Virus Vaccine Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Inactivated Polio Virus Vaccine Market Share by Region (2026-2031)

Table 11. Inactivated Polio Virus Vaccine Market Trends

Table 12. Inactivated Polio Virus Vaccine Market Drivers

Table 13. Inactivated Polio Virus Vaccine Market Challenges

Table 14. Inactivated Polio Virus Vaccine Market Restraints

Table 15. Global Inactivated Polio Virus Vaccine Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Inactivated Polio Virus Vaccine Market Share by Players (2020-2025)

Table 17. Global Top Inactivated Polio Virus Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inactivated Polio Virus Vaccine as of 2024)

Table 18. Ranking of Global Top Inactivated Polio Virus Vaccine Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Inactivated Polio Virus Vaccine Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Inactivated Polio Virus Vaccine, Headquarters and Area Served

Table 21. Global Key Players of Inactivated Polio Virus Vaccine, Product and Application

Table 22. Global Key Players of Inactivated Polio Virus Vaccine, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Inactivated Polio Virus Vaccine Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Inactivated Polio Virus Vaccine Revenue Market Share by Type (2020-2025)

Table 26. Global Inactivated Polio Virus Vaccine Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Inactivated Polio Virus Vaccine Revenue Market Share by Type (2026-2031)

Table 28. Global Inactivated Polio Virus Vaccine Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Inactivated Polio Virus Vaccine Revenue Market Share by Application (2020-2025)

Table 30. Global Inactivated Polio Virus Vaccine Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Inactivated Polio Virus Vaccine Revenue Market Share by Application (2026-2031)

Table 32. North America Inactivated Polio Virus Vaccine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Inactivated Polio Virus Vaccine Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Inactivated Polio Virus Vaccine Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Inactivated Polio Virus Vaccine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Inactivated Polio Virus Vaccine Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Inactivated Polio Virus Vaccine Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Inactivated Polio Virus Vaccine Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Inactivated Polio Virus Vaccine Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Inactivated Polio Virus Vaccine Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Inactivated Polio Virus Vaccine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Inactivated Polio Virus Vaccine Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Inactivated Polio Virus Vaccine Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Inactivated Polio Virus Vaccine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Inactivated Polio Virus Vaccine Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Inactivated Polio Virus Vaccine Market Size by Country (2026-2031) & (US$ Million)

Table 47. Sanofi Company Details

Table 48. Sanofi Business Overview

Table 49. Sanofi Inactivated Polio Virus Vaccine Product

Table 50. Sanofi Revenue in Inactivated Polio Virus Vaccine Business (2020-2025) & (US$ Million)

Table 51. Sanofi Recent Development

Table 52. GSK Company Details

Table 53. GSK Business Overview

Table 54. GSK Inactivated Polio Virus Vaccine Product

Table 55. GSK Revenue in Inactivated Polio Virus Vaccine Business (2020-2025) & (US$ Million)

Table 56. GSK Recent Development

Table 57. Serum Institute (Bilthoven Biologicals) Company Details

Table 58. Serum Institute (Bilthoven Biologicals) Business Overview

Table 59. Serum Institute (Bilthoven Biologicals) Inactivated Polio Virus Vaccine Product

Table 60. Serum Institute (Bilthoven Biologicals) Revenue in Inactivated Polio Virus Vaccine Business (2020-2025) & (US$ Million)

Table 61. Serum Institute (Bilthoven Biologicals) Recent Development

Table 62. IMBCA Company Details

Table 63. IMBCA Business Overview

Table 64. IMBCA Inactivated Polio Virus Vaccine Product

Table 65. IMBCA Revenue in Inactivated Polio Virus Vaccine Business (2020-2025) & (US$ Million)

Table 66. IMBCA Recent Development

Table 67. Research Programs/Design for This Report

Table 68. Key Data Information from Secondary Sources

Table 69. Key Data Information from Primary Sources

Table 70. Authors List of This Report

List of Figures

Figure 1. Inactivated Polio Virus Vaccine Picture

Figure 2. Global Inactivated Polio Virus Vaccine Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Inactivated Polio Virus Vaccine Market Share by Type: 2024 VS 2031

Figure 4. Type I Features

Figure 5. Type II Features

Figure 6. Type III Features

Figure 7. Global Inactivated Polio Virus Vaccine Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Inactivated Polio Virus Vaccine Market Share by Application: 2024 VS 2031

Figure 9. Hospital Case Studies

Figure 10. Clinic Case Studies

Figure 11. Inactivated Polio Virus Vaccine Report Years Considered

Figure 12. Global Inactivated Polio Virus Vaccine Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Inactivated Polio Virus Vaccine Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Inactivated Polio Virus Vaccine Market Share by Region: 2024 VS 2031

Figure 15. Global Inactivated Polio Virus Vaccine Market Share by Players in 2024

Figure 16. Global Top Inactivated Polio Virus Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inactivated Polio Virus Vaccine as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Inactivated Polio Virus Vaccine Revenue in 2024

Figure 18. North America Inactivated Polio Virus Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Inactivated Polio Virus Vaccine Market Share by Country (2020-2031)

Figure 20. United States Inactivated Polio Virus Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Inactivated Polio Virus Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Inactivated Polio Virus Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Inactivated Polio Virus Vaccine Market Share by Country (2020-2031)

Figure 24. Germany Inactivated Polio Virus Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Inactivated Polio Virus Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Inactivated Polio Virus Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Inactivated Polio Virus Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Inactivated Polio Virus Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Inactivated Polio Virus Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Inactivated Polio Virus Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Inactivated Polio Virus Vaccine Market Share by Region (2020-2031)

Figure 32. China Inactivated Polio Virus Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Inactivated Polio Virus Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Inactivated Polio Virus Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Inactivated Polio Virus Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Inactivated Polio Virus Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Inactivated Polio Virus Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Inactivated Polio Virus Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Inactivated Polio Virus Vaccine Market Share by Country (2020-2031)

Figure 40. Mexico Inactivated Polio Virus Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Inactivated Polio Virus Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Inactivated Polio Virus Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Inactivated Polio Virus Vaccine Market Share by Country (2020-2031)

Figure 44. Turkey Inactivated Polio Virus Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Inactivated Polio Virus Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Inactivated Polio Virus Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Sanofi Revenue Growth Rate in Inactivated Polio Virus Vaccine Business (2020-2025)

Figure 48. GSK Revenue Growth Rate in Inactivated Polio Virus Vaccine Business (2020-2025)

Figure 49. Serum Institute (Bilthoven Biologicals) Revenue Growth Rate in Inactivated Polio Virus Vaccine Business (2020-2025)

Figure 50. IMBCA Revenue Growth Rate in Inactivated Polio Virus Vaccine Business (2020-2025)

Figure 51. Bottom-up and Top-down Approaches for This Report

Figure 52. Data Triangulation

Figure 53. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions